Redhill Capital

Redhill Capital (“Redhill”) is a venture capital firm focusing on early and growth-stage investments in the field of medical innovation. Redhill was jointly founded in early 2018 by Cherry Lu, a former partner at Hongshan, and Frank Su, a former partner at Share Capital. Since its inception, Redhill has been a key player in the Chinese healthcare and life science scene, introducing new medical technologies, innovative drugs, and novel medical services.

 

http://www.redhillcapital.cn